---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-291441"
form_type: "8-K"
ticker: "ORCL"
cik: "0001341439"
company_name: "ORACLE CORP"
filed_at: "2025-11-21T23:59:59+00:00"
generated_at: "2026-05-16T17:34:36.827035+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Oracle adds former Quest CEO Stephen Rusckowski to board; all 13 directors re-elected at annual meeting

## Summary
- Stephen Rusckowski elected to Oracle's board effective Nov 18, 2025; board size increased to 14.
- Rusckowski was former CEO and President of Quest Diagnostics (2012–2022) and previously CEO of Philips Healthcare.
- 2025 annual meeting results: all 13 director nominees elected, advisory say-on-pay passed (1.92B for, 424M against), and Ernst & Young ratified as auditor (2.55B for).
- Rusckowski will receive pro-rata RSUs under Oracle's director stock plan and standard cash compensation.

## SEC filing metadata
- accession: 0001193125-25-291441
- form_type: 8-K
- ticker: ORCL
- cik: 0001341439
- company_name: ORACLE CORP
- filed_at: 2025-11-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1341439/000119312525291441/0001193125-25-291441-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1341439/000119312525291441/d43173d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-291441
- JSON: https://secwatch.observer/filing/0001193125-25-291441.json
- Plain text: https://secwatch.observer/filing/0001193125-25-291441.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
